Free Trial

Spire Healthcare Group (LON:SPI) Stock Price Up 14.1% - Here's What Happened

Spire Healthcare Group logo with Medical background

Key Points

  • Spire Healthcare Group's shares experienced a significant increase of 14.1%, trading as high as GBX 256.50 ($3.46) during mid-day trading, with a notable volume of 9.7 million shares exchanged.
  • Wall Street analysts maintain a positive outlook with an average rating of "Buy" and a consensus price target of GBX 294.33, reflecting confidence in the stock's potential for growth.
  • Spire Healthcare Group reported earnings of GBX 4.10 per share for the last quarter and is expected to achieve approximately 15.66 earnings per share for the current fiscal year.
  • Five stocks we like better than Spire Healthcare Group.

Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price rose 14.1% during mid-day trading on Friday . The stock traded as high as GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33). Approximately 9,747,062 shares were traded during trading, an increase of 563% from the average daily volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.92).

Wall Street Analysts Forecast Growth

SPI has been the subject of several recent analyst reports. Berenberg Bank restated a "buy" rating and set a GBX 280 price objective on shares of Spire Healthcare Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. lowered their price objective on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a research note on Tuesday, August 5th. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of GBX 294.33.

Read Our Latest Research Report on Spire Healthcare Group

Spire Healthcare Group Trading Up 14.1%

The business's fifty day simple moving average is GBX 218.75 and its two-hundred day simple moving average is GBX 203.41. The company has a market cap of £993.86 million, a price-to-earnings ratio of 5,369.57, a PEG ratio of 1.06 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25.

Spire Healthcare Group (LON:SPI - Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. On average, equities analysts predict that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

Spire Healthcare Group Company Profile

(Get Free Report)

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Further Reading

Should You Invest $1,000 in Spire Healthcare Group Right Now?

Before you consider Spire Healthcare Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.

While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.